Zobrazeno 1 - 10
of 1 239
pro vyhledávání: '"Ehling M"'
Autor:
Gioelli N; Department of Oncology, University of Torino School of Medicine, Candiolo (TO), Italy.; Candiolo Cancer Institute - Fondazione del Piemonte per l'Oncologia (FPO) Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Candiolo (TO), Italy., Neilson LJ; Cancer Research UK Beatson Institute, Glasgow, UK., Wei N; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, 92037, USA., Villari G; Department of Oncology, University of Torino School of Medicine, Candiolo (TO), Italy.; Candiolo Cancer Institute - Fondazione del Piemonte per l'Oncologia (FPO) Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Candiolo (TO), Italy., Chen W; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, 92037, USA., Kuhle B; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, 92037, USA., Ehling M; Center for Cancer Biology, Department of Oncology, University of Leuven, Leuven, 3000, Belgium.; Center for Cancer Biology, VIB, Leuven, 3000, Belgium., Maione F; Department of Oncology, University of Torino School of Medicine, Candiolo (TO), Italy.; Candiolo Cancer Institute - Fondazione del Piemonte per l'Oncologia (FPO) Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Candiolo (TO), Italy., Willox S; Center for Cancer Biology, Department of Oncology, University of Leuven, Leuven, 3000, Belgium.; Center for Cancer Biology, VIB, Leuven, 3000, Belgium., Brundu S; Candiolo Cancer Institute - Fondazione del Piemonte per l'Oncologia (FPO) Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Candiolo (TO), Italy.; Department of Science and Drug Technology, University of Torino, Torino, Italy., Avanzato D; Department of Oncology, University of Torino School of Medicine, Candiolo (TO), Italy.; Candiolo Cancer Institute - Fondazione del Piemonte per l'Oncologia (FPO) Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Candiolo (TO), Italy., Koulouras G; Cancer Research UK Beatson Institute, Glasgow, UK., Mazzone M; Center for Cancer Biology, Department of Oncology, University of Leuven, Leuven, 3000, Belgium.; Center for Cancer Biology, VIB, Leuven, 3000, Belgium.; Department of Science and Drug Technology, University of Torino, Torino, Italy.; Molecular Biotechnology Center (MBC), University of Torino, Torino, Italy.; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy., Giraudo E; Candiolo Cancer Institute - Fondazione del Piemonte per l'Oncologia (FPO) Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Candiolo (TO), Italy.; Department of Science and Drug Technology, University of Torino, Torino, Italy., Yang XL; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, 92037, USA., Valdembri D; Department of Oncology, University of Torino School of Medicine, Candiolo (TO), Italy.; Candiolo Cancer Institute - Fondazione del Piemonte per l'Oncologia (FPO) Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Candiolo (TO), Italy., Zanivan S; Cancer Research UK Beatson Institute, Glasgow, UK. S.Zanivan@beatson.gla.ac.uk.; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. S.Zanivan@beatson.gla.ac.uk., Serini G; Department of Oncology, University of Torino School of Medicine, Candiolo (TO), Italy. guido.serini@ircc.it.; Candiolo Cancer Institute - Fondazione del Piemonte per l'Oncologia (FPO) Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Candiolo (TO), Italy. guido.serini@ircc.it.
Publikováno v:
Nature communications [Nat Commun] 2022 Jul 20; Vol. 13 (1), pp. 4188. Date of Electronic Publication: 2022 Jul 20.
Autor:
Chan, Hui-Wen1 (AUTHOR) viator70757@gmail.com, Kuo, Deng-Yu2 (AUTHOR), Shueng, Pei-Wei2,3 (AUTHOR), Chuang, Hui-Yen1 (AUTHOR) huiyen@nycu.edu.tw
Publikováno v:
Pharmaceuticals (14248247). Dec2024, Vol. 17 Issue 12, p1663. 22p.
Autor:
Ummarino, Aldo1,2 (AUTHOR) aldo.ummarino@childrens.harvard.edu, Calà, Nicholas3 (AUTHOR) ncala@scienzebiomediche.it, Allavena, Paola2 (AUTHOR) paola.allavena@hunimed.eu
Publikováno v:
International Journal of Molecular Sciences. Nov2024, Vol. 25 Issue 22, p12403. 16p.
Autor:
Kovner, Anna1 (AUTHOR) anya.kovner@gmail.com, Kapushchak, Yaroslav1 (AUTHOR) zp.oksana.93@gmail.com, Zaparina, Oxana1 (AUTHOR) p.dmitr@outlook.com, Ponomarev, Dmitry1 (AUTHOR) pmaria@yandex.ru, Pakharukova, Maria1,2 (AUTHOR)
Publikováno v:
International Journal of Molecular Sciences. Nov2024, Vol. 25 Issue 22, p12002. 20p.
Autor:
Cao, Le1 (AUTHOR), Sun, Kai1 (AUTHOR), Zeng, Ran2 (AUTHOR), Yang, Haitao1 (AUTHOR) yang56863789@163.com
Publikováno v:
Journal of Translational Medicine. 11/8/2024, Vol. 22 Issue 1, p1-21. 21p.
Autor:
García-Martín, Adela1,2,3 (AUTHOR) bc2gamam@uco.es, Prados, María E.1,2,3 (AUTHOR), Lastres-Cubillo, Isabel1,3 (AUTHOR), Ponce-Diaz, Francisco J.1,2,3 (AUTHOR), Cerero, Laura1,2,3 (AUTHOR), Garrido-Rodríguez, Martin4 (AUTHOR), Navarrete, Carmen1,3 (AUTHOR), Pineda, Rafael1,2,3 (AUTHOR), Rodríguez, Ana B.1,2,3 (AUTHOR), Muñoz, Ignacio1,3 (AUTHOR), Moya, Javier1,3 (AUTHOR), Medeot, Antonella1,3 (AUTHOR), Moreno, José A.1,3 (AUTHOR), Chacón, Antonio1,3 (AUTHOR), García-Revillo, José1,3 (AUTHOR), Muñoz, Eduardo1,2,3 (AUTHOR) fi1muble@uco.es
Publikováno v:
Journal of Translational Medicine. 11/6/2024, Vol. 22 Issue 1, p1-24. 24p.
Autor:
Fiorino, Erika1 (AUTHOR) erika.fiorino@unito.it, Rossin, Daniela1 (AUTHOR), Vanni, Roberto1 (AUTHOR), Aubry, Matteo1 (AUTHOR), Giachino, Claudia1 (AUTHOR), Rastaldo, Raffaella1 (AUTHOR) raffaella.rastaldo@unito.it
Publikováno v:
International Journal of Molecular Sciences. Nov2024, Vol. 25 Issue 21, p11747. 39p.
Autor:
Kiss M; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium.; Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium., Vande Walle L; VIB Center for Inflammation Research, Ghent, Belgium.; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium., Saavedra PHV; VIB Center for Inflammation Research, Ghent, Belgium.; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium., Lebegge E; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium.; Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium., Van Damme H; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium.; Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium., Murgaski A; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium.; Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium., Qian J; Laboratory of Translational Genetics, VIB Center for Cancer Biology, Leuven, Belgium.; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium., Ehling M; Laboratory of Tumor Inflammation and Angiogenesis, VIB Center for Cancer Biology, Leuven, Belgium.; Laboratory of Tumor Inflammation and Angiogenesis, Department of Oncology, KU Leuven, Leuven, Belgium., Pretto S; Laboratory of Tumor Inflammation and Angiogenesis, VIB Center for Cancer Biology, Leuven, Belgium.; Laboratory of Tumor Inflammation and Angiogenesis, Department of Oncology, KU Leuven, Leuven, Belgium., Bolli E; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium.; Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium., Keirsse J; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium.; Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium., Bardet PMR; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium.; Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium., Arnouk SM; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium.; Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium., Elkrim Y; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium.; Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium., Schmoetten M; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium.; Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium., Brughmans J; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium.; Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium., Debraekeleer A; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium.; Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium., Fossoul A; VIB Center for Inflammation Research, Ghent, Belgium.; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium., Boon L; Polpharma Biologics, Utrecht, the Netherlands., Raes G; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium.; Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium., van Loo G; VIB Center for Inflammation Research, Ghent, Belgium.; Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium., Lambrechts D; Laboratory of Translational Genetics, VIB Center for Cancer Biology, Leuven, Belgium.; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium., Mazzone M; Laboratory of Tumor Inflammation and Angiogenesis, VIB Center for Cancer Biology, Leuven, Belgium.; Laboratory of Tumor Inflammation and Angiogenesis, Department of Oncology, KU Leuven, Leuven, Belgium., Beschin A; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium.; Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium., Wullaert A; VIB Center for Inflammation Research, Ghent, Belgium.; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.; Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium., Lamkanfi M; VIB Center for Inflammation Research, Ghent, Belgium.; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium., Van Ginderachter JA; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium. dlaoui@vub.be jo.van.ginderachter@vub.be.; Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium., Laoui D; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium. dlaoui@vub.be jo.van.ginderachter@vub.be.; Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2021 Mar; Vol. 9 (3), pp. 309-323. Date of Electronic Publication: 2020 Dec 23.
Autor:
Menga A; Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology (CCB), VIB, Leuven, Belgium.; Laboratory of Tumor Inflammation and Angiogenesis, Department of Oncology, KU Leuven, Leuven, Belgium.; Department of Molecular Biotechnology and Health Science, Molecular Biotechnology Centre, University of Torino, Torino, Italy.; Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, Bari, Italy., Serra M; Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology (CCB), VIB, Leuven, Belgium.; Laboratory of Tumor Inflammation and Angiogenesis, Department of Oncology, KU Leuven, Leuven, Belgium., Todisco S; Department of Sciences, University of Basilicata, Potenza, Italy., Riera-Domingo C; Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology (CCB), VIB, Leuven, Belgium.; Laboratory of Tumor Inflammation and Angiogenesis, Department of Oncology, KU Leuven, Leuven, Belgium., Ammarah U; Department of Molecular Biotechnology and Health Science, Molecular Biotechnology Centre, University of Torino, Torino, Italy., Ehling M; Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology (CCB), VIB, Leuven, Belgium.; Laboratory of Tumor Inflammation and Angiogenesis, Department of Oncology, KU Leuven, Leuven, Belgium., Palmieri EM; Cancer & Inflammation Program, National Cancer Institute, Frederick, MD, USA., Di Noia MA; Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, Bari, Italy., Gissi R; Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, Bari, Italy., Favia M; Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, Bari, Italy., Pierri CL; Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, Bari, Italy., Porporato PE; Department of Molecular Biotechnology and Health Science, Molecular Biotechnology Centre, University of Torino, Torino, Italy., Castegna A; Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, Bari, Italy.; IBIOM-CNR, Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies, National Research Council, Bari, Italy., Mazzone M; Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology (CCB), VIB, Leuven, Belgium.; Laboratory of Tumor Inflammation and Angiogenesis, Department of Oncology, KU Leuven, Leuven, Belgium.; Department of Molecular Biotechnology and Health Science, Molecular Biotechnology Centre, University of Torino, Torino, Italy.
Publikováno v:
EMBO molecular medicine [EMBO Mol Med] 2020 Oct 07; Vol. 12 (10), pp. e11210. Date of Electronic Publication: 2020 Sep 04.
Autor:
Ehling M; From the Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology (CCB), VIB, Leuven, Belgium (M.E., W.C., R.M.-P., R.A.-R., S.W., D.P., G.D.C., M.M.).; Laboratory of Tumor Inflammation and Angiogenesis, and Department of Oncology (M.E., W.C., R.M.-P., R.A.-R., S.W., D.P., G.D.C., M.M.), KU Leuven, Belgium., Celus W; From the Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology (CCB), VIB, Leuven, Belgium (M.E., W.C., R.M.-P., R.A.-R., S.W., D.P., G.D.C., M.M.).; Laboratory of Tumor Inflammation and Angiogenesis, and Department of Oncology (M.E., W.C., R.M.-P., R.A.-R., S.W., D.P., G.D.C., M.M.), KU Leuven, Belgium., Martín-Pérez R; From the Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology (CCB), VIB, Leuven, Belgium (M.E., W.C., R.M.-P., R.A.-R., S.W., D.P., G.D.C., M.M.).; Laboratory of Tumor Inflammation and Angiogenesis, and Department of Oncology (M.E., W.C., R.M.-P., R.A.-R., S.W., D.P., G.D.C., M.M.), KU Leuven, Belgium., Alba-Rovira R; From the Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology (CCB), VIB, Leuven, Belgium (M.E., W.C., R.M.-P., R.A.-R., S.W., D.P., G.D.C., M.M.).; Laboratory of Tumor Inflammation and Angiogenesis, and Department of Oncology (M.E., W.C., R.M.-P., R.A.-R., S.W., D.P., G.D.C., M.M.), KU Leuven, Belgium.; Vasculitis Research Unit, Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona (R.A.-R., M.C.C.)., Willox S; From the Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology (CCB), VIB, Leuven, Belgium (M.E., W.C., R.M.-P., R.A.-R., S.W., D.P., G.D.C., M.M.).; Laboratory of Tumor Inflammation and Angiogenesis, and Department of Oncology (M.E., W.C., R.M.-P., R.A.-R., S.W., D.P., G.D.C., M.M.), KU Leuven, Belgium., Ponti D; From the Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology (CCB), VIB, Leuven, Belgium (M.E., W.C., R.M.-P., R.A.-R., S.W., D.P., G.D.C., M.M.).; Laboratory of Tumor Inflammation and Angiogenesis, and Department of Oncology (M.E., W.C., R.M.-P., R.A.-R., S.W., D.P., G.D.C., M.M.), KU Leuven, Belgium.; Medical-Surgical Sciences and Biotechnologies, University of Rome Sapienza, Latina (D.P.)., Cid MC; Vasculitis Research Unit, Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona (R.A.-R., M.C.C.)., Jones EAV; Department of Cardiovascular Sciences (E.A.V.J.), KU Leuven, Belgium., Di Conza G; From the Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology (CCB), VIB, Leuven, Belgium (M.E., W.C., R.M.-P., R.A.-R., S.W., D.P., G.D.C., M.M.).; Laboratory of Tumor Inflammation and Angiogenesis, and Department of Oncology (M.E., W.C., R.M.-P., R.A.-R., S.W., D.P., G.D.C., M.M.), KU Leuven, Belgium., Mazzone M; From the Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology (CCB), VIB, Leuven, Belgium (M.E., W.C., R.M.-P., R.A.-R., S.W., D.P., G.D.C., M.M.).; Laboratory of Tumor Inflammation and Angiogenesis, and Department of Oncology (M.E., W.C., R.M.-P., R.A.-R., S.W., D.P., G.D.C., M.M.), KU Leuven, Belgium.
Publikováno v:
Circulation research [Circ Res] 2020 Aug 28; Vol. 127 (6), pp. 707-723. Date of Electronic Publication: 2020 Jun 12.